Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations

BACKGROUND: Although autoantibodies are an important hallmark of systemic lupus erythematosus (SLE), most are not specific for SLE or any of its clinical manifestations. Autoantibodies against post-translationally modified (PTM) proteins have been studied extensively in rheumatoid arthritis and asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Monahan, Rory C, van den Beukel, Michelle D, Borggreven, Nicole V, Fronczek, Rolf, Huizinga, Tom W J, Kloppenburg, Margreet, Steup-Beekman, Gerda M, Trouw, Leendert A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Lupus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024229/
https://www.ncbi.nlm.nih.gov/pubmed/35450955
http://dx.doi.org/10.1136/rmdopen-2021-002079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024229/
https://www.ncbi.nlm.nih.gov/pubmed/35450955
http://dx.doi.org/10.1136/rmdopen-2021-002079

Ejemplares similares